May 26, 2013 1:27 AM ET

Pharmaceuticals

Company Overview of CoLucid Pharmaceuticals, Inc.

Company Overview

CoLucid Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of central nervous system disorders. Its pipeline includes Lasmiditan, a neurally acting anti-migraine agent that is designed to deliver efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies; COL-204 for wake promotion; and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease, and psychiatric disorders. CoLucid Pharmaceuticals, Inc. was founded in 2005 and is based in Durham, North Carolina.

2530 Meridian Parkway

Suite 300

Durham, NC 27713

United States

Founded in 2005

Phone:

919-806-4304

Fax:

919-806-4301

www.colucid.com

Key Executives for CoLucid Pharmaceuticals, Inc.

Chief Executive Officer and Director
Age: 46
Chief Financial Officer
Chief Medical Officer
Legal Counsel and Director
Vice President of Business Development
Compensation as of Fiscal Year 2012.

CoLucid Pharmaceuticals, Inc. Key Developments

CoLucid Pharmaceuticals, Inc. Presents at 15th Annual Bio CEO & Investor Conference, Feb-11-2013 10:00 AM

CoLucid Pharmaceuticals, Inc. Presents at 15th Annual Bio CEO & Investor Conference, Feb-11-2013 10:00 AM. Venue: The Waldorf Astoria, 301 Park Avenue, New York, NY 10022, United States.

CoLucid Pharmaceuticals, Inc. Presents at BIO-Europe 2012, Nov-12-2012

CoLucid Pharmaceuticals, Inc. Presents at BIO-Europe 2012, Nov-12-2012 . Venue: CCH Congress Center Hamburg, Am Dammtor / Marseiller Str, 20355 Hamburg, Germany. Speakers: Linda C. Hogan, Vice President of Business Development, Thomas P. Mathers, Chief Executive Officer.

CoLucid Pharmaceuticals, Inc. Presents at The 11th Annual BIO Investor Forum 2012, Oct-09-2012 11:30 AM

CoLucid Pharmaceuticals, Inc. Presents at The 11th Annual BIO Investor Forum 2012, Oct-09-2012 11:30 AM. Venue: Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Elan Pharmaceutical Investments Ltd. United States
Checkpoint Genetics United States
Avidity, LLC United States
PEGUS Research, Inc. United States
Shionogi USA, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CoLucid Pharmaceuticals, Inc., please visit www.colucid.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.